ClinicalTrials.Veeva

Menu

Sexual Risks in Prep Users (PREP)

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

Sexually Transmitted Diseases
Vaccinations
HIV Infection
Prep Prescription

Treatments

Behavioral: PrEP

Study type

Observational

Funder types

Other

Identifiers

NCT03975517
7300 (Other Identifier)

Details and patient eligibility

About

Primary purpose of the study: to describe sexual behavior of Prep users, whatever mode of intake, ie continuous or on-demand; it has been shown in some studies, an increase of sexual risks in Prep users, and therefore an similar increase of STIs (sexually transmitted diseases); using a self-questionnaire, we'd like to evaluate sexual behavior before, and 6 months after, starting Prep.

Secondary purposes: to describe medical characteristics of Prep users (past medical condition, demographic characteristics, vaccinations, kidney function, serological results, urine and anal/pharyngeal swabs), clinical and biological Prep safety, STIs occurrence, and antibiotic prescriptions, continuous or on-demand intake, Prep indication.

Enrollment

200 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • non HIV-infected subjects
  • men aged 18 years or older
  • having non protected sexual relationship
  • taking Prep (emtricitable/tenofovir disoproxil fumarate) either every day, or on-demand
  • affiliated to social security

Exclusion criteria

  • HIV-infected patients
  • refusal of study participation
  • not on Prep
  • not fluent in French language
  • safeguarding justice
  • on guardianship or trusteeship

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems